Young Jonathan

CIK 00017798051 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001779805

Recent Transactions

50 trades

Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−3,421→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−84,051→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−141,205→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Common Stock
2025-12-09−20,000→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−70,279→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−2,328→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−29,073→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Common Stock
2025-12-09−47,573→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−44,982→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−74,053→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−5,032→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−29,074→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Common Stock
2025-12-09−152,616→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−28,584→ 0 total
Gift
Akero Therapeutics, Inc.
Common Stock
2025-11-26−9,259→ 200,189 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-11-24−4,739→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-11-24$21.10/sh+4,739→ 209,448 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-11-24−3,527→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-11-24−4,284→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-11-24$28.35/sh+3,527→ 204,709 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-11-24$21.09/sh+4,284→ 201,182 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-10-01−12,500→ 44,982 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-10-01$21.10/sh+12,500→ 209,398 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-10-01$47.64/sh−8,299→ 201,099 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-10-01$47.98/sh−4,201→ 196,898 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-09-11$43.02/sh−586→ 196,898 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-09-02$45.78/sh−9,700→ 200,284 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-09-02$21.10/sh+12,500→ 209,984 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-09-02−12,500→ 57,482 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-09-02$47.14/sh−2,739→ 197,545 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-09-02$47.58/sh−61→ 197,484 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-08-12$21.10/sh+12,500→ 209,984 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-08-12$47.72/sh−11,151→ 198,833 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-08-12−12,500→ 69,982 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-08-12$48.32/sh−1,349→ 197,484 total
Award
Akero Therapeutics, Inc.
Common Stock
2025-06-30$23.87/sh+890→ 197,484 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-06-18$54.84/sh−1,453→ 196,594 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-06-10$53.99/sh−2,493→ 198,047 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-03-12$44.88/sh−607→ 200,540 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-03-04$44.17/sh−11,447→ 239,700 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-03-04$45.07/sh−38,553→ 201,147 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-02-03$54.06/sh−4,900→ 251,147 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-02-03$53.56/sh−5,100→ 256,047 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-01-24$6.36/sh+43,064→ 261,147 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-01-23−43,064→ 0 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-01-02$28.03/sh−10,000→ 218,083 total
Award
Akero Therapeutics, Inc.
Common Stock
2024-12-16+24,300→ 228,083 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2024-12-16+73,700→ 73,700 total
Sale
Akero Therapeutics, Inc.
Common Stock
2024-12-10$30.79/sh−2,503→ 203,783 total
Sale
Akero Therapeutics, Inc.
Common Stock
2024-12-02$32.13/sh−10,000→ 206,286 total

Companies

Akero Therapeutics, Inc.
Chief Operating Officer

Recent Filings

Address

C/O AKERO THERAPEUTICS, INC. 601 GATEWAY BOULEVARD, SUITE 350

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov